NCT04753736View on ClinicalTrials.gov

Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 24, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Infertility, Female
Interventions
PROCEDURE

Intrauterine administration of hCG-activated peripheral blood mononuclear cells

Intrauterine administration of hCG-activated peripheral blood mononuclear cells

Trial Locations (1)

H7S1Z5

Fertilys, Laval

Sponsors

Lead Sponsor

Fertilys
All Listed Sponsors
collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

lead

Fertilys

INDUSTRY

NCT04753736 - Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC | Biotech Hunter | Biotech Hunter